Quantamental Technologies LLC decreased its holdings in Petmed Express Inc (NASDAQ:PETS) by 52.4% during the first quarter, Holdings Channel reports. The institutional investor owned 1,451 shares of the company’s stock after selling 1,596 shares during the quarter. Quantamental Technologies LLC’s holdings in Petmed Express were worth $33,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. lifted its holdings in Petmed Express by 1.1% during the fourth quarter. BlackRock Inc. now owns 3,076,147 shares of the company’s stock valued at $71,550,000 after purchasing an additional 33,290 shares in the last quarter. Epoch Investment Partners Inc. lifted its holdings in Petmed Express by 47.9% during the fourth quarter. Epoch Investment Partners Inc. now owns 1,268,358 shares of the company’s stock valued at $29,502,000 after purchasing an additional 410,636 shares in the last quarter. LSV Asset Management lifted its holdings in Petmed Express by 624.1% during the fourth quarter. LSV Asset Management now owns 564,787 shares of the company’s stock valued at $13,136,000 after purchasing an additional 486,787 shares in the last quarter. River Road Asset Management LLC purchased a new position in Petmed Express during the fourth quarter valued at approximately $11,022,000. Finally, Bank of New York Mellon Corp lifted its holdings in Petmed Express by 24.4% during the fourth quarter. Bank of New York Mellon Corp now owns 434,514 shares of the company’s stock valued at $10,107,000 after purchasing an additional 85,173 shares in the last quarter. 95.04% of the stock is currently owned by institutional investors.

Several equities analysts have weighed in on the stock. BidaskClub raised shares of Petmed Express from a “sell” rating to a “hold” rating in a report on Wednesday, January 16th. ValuEngine cut shares of Petmed Express from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. Finally, Craig Hallum reduced their price objective on shares of Petmed Express from $25.00 to $18.00 and set a “sell” rating on the stock in a research report on Wednesday, January 23rd. Three equities research analysts have rated the stock with a sell rating and two have given a hold rating to the stock. Petmed Express currently has a consensus rating of “Sell” and an average target price of $18.00.

Petmed Express stock opened at $20.37 on Thursday. The company has a market cap of $407.41 million, a PE ratio of 10.40 and a beta of 0.47. Petmed Express Inc has a 1 year low of $18.84 and a 1 year high of $46.83.

Petmed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, May 6th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.46 by ($0.14). The company had revenue of $64.57 million for the quarter, compared to the consensus estimate of $69.06 million. Petmed Express had a net margin of 13.32% and a return on equity of 28.96%. The company’s quarterly revenue was down 4.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.50 EPS.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 24th. Stockholders of record on Friday, May 17th will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 5.30%. The ex-dividend date of this dividend is Thursday, May 16th.

ILLEGAL ACTIVITY WARNING: This article was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://theolympiareport.com/2019/05/16/quantamental-technologies-llc-reduces-position-in-petmed-express-inc-pets.html.

Petmed Express Company Profile

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Further Reading: How do taxes affect a CDs total return?

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).

Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.